Mark Bodmer Email & Phone Number
Chief Executive Officer @ Nucleome Therapeutics
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Mark Bodmer Location
- Oxford, GB
Mark Bodmer Work
- Chief Executive Officer @ (July 2024 - Present)
- CSO @ (April 2016 - February 2024)
- Chief Executive Officer @ (January 2004 - December 2007)
- VP NewMedicines Therapeutics @ (January 2012 - April 2016)
- SVP ImmunoInflammation CEDD @ GSK (January 2009 - January 2011)
- SVP R and D Incyte and President of Incyte Europe (formerly Hexagen) @ Incyte (January 1998 - December 2000)
- SVP Cardiovascular and Metabolic CEDD @ GSK (January 2007 - January 2009)
- SVP ImmunoInflammation CEDD @ GSK (January 2009 - December 2011)
- Chief Executive Officer @ (January 2004 - January 2007)
- Chief Executive Officer @ Lorantis (January 2000 - January 2004)
- SVP Cardiovascular and Metabolic CEDD @ GSK (January 2007 - December 2009)
- Chief Executive Officer @ Lorantis (January 2000 - December 2004)
- SVP R and D Incyte and President of Incyte Europe (formerly Hexagen) @ Incyte (January 1998 - January 2000)
- Chief Executive Officer @ Hexagen (January 1996 - January 1998)
- Chief Executive Officer @ Hexagen (January 1996 - December 1998)
- Head of Immunology and Antibody Therapeutics @ (January 1985 - January 1996)
- Head of Immunology and Antibody Therapeutics @ (January 1985 - December 1996)
- Scientist and Senior Scientist @ (January 1982 - December 1985)
- Scientist and Senior Scientist @ (January 1982 - January 1985)
Mark Bodmer Education
- University of Cambridge
Doctor of Philosophy (Ph.D.) (Genetics)
1979-1982 - University of Cambridge
BA (Natural Sciences)
1976-1979 - University of Cambridge
BA, Natural Sciences
1976-1979
Mark Bodmer Skills
- Microsoft Office
- Microsoft Excel
- Microsoft Word
- Customer Service
- PowerPoint
- English
- Windows
- Research
- Outlook
- Teaching
- Photoshop
- Public Speaking
- HTML
- Strategic Planning
- Budgets
- Clinical Development
- Life Sciences
- Pharmaceutical Industry
- Clinical Trials
- Drug Development
- Biotechnology
- Drug Discovery
- Strategic Alliances
- Leadership
- Sales
- Program Management
- Project Management
- Marketing
- Immunology
- Oncology
- Strategy
- Biopharmaceuticals
- Technology Transfer
- Molecular Biology
- Biochemistry
- Process Improvement
- Marketing Strategy
- R&d
- Team Building
- Contract Management
- Arc Welding
- MIG welding
- Construction Management
- AutoCAD
- Engineering
- Construction
- Metal Fabrication
- Supervisory Skills
- Welding
- Contract Negotiation
- Project Planning
- Management
- Inspection
Mark Bodmer Summary
- Mark Bodmer, based in Oxford, GB, is currently a Chief Executive Officer at Nucleome Therapeutics. Mark Bodmer brings experience from previous roles at Evelo Biosciences, Biotica, UCB and GSK. Mark Bodmer holds a 1979 - 1982 Doctor of Philosophy (Ph.D.) in Genetics @ University of Cambridge. With a robust skill set that includes Microsoft Office, Microsoft Excel, Microsoft Word, Customer Service, PowerPoint and more. Mark Bodmer has 3 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Mark Bodmer?
Find contact details for 700 million professionals.
Others Named Mark Bodmer
Mark Bodmer
General Manager
Dallas, TX, US
Mark Bodmer
General Manager
Carrollton, TX, US
Mark Bodmer
Senior Consultant
Boulder, CO, US
Mark Bodmer
Section Manager Facilities
Bath, ME, US
Top Nucleome Therapeutics Employees
Mark Bodmer
Chief Executive Officer
Oxford, GB
Roslin Russell
Vice President Computational Biology
United Kingdom
Emma Morton
SVP Finance and Lab Operations
Oxford, GB
Bhavna Hunjan
Chief Business Officer
London, GB
Justyna Dopierala
Principal Computational Biologist
Bishop's Stortford, GB
Kirsty Waddington
Principal Scientist
United Kingdom
James Heward
VP, Functional Genomics
Didcot, GB
Stephanie Maley
Chief People Officer
London, GB
Chantal Hargreaves
Director - Drug Discovery
Oxford, GB
Polly Weston
Director of Administration
Oxford, GB
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co